Financials

Regional Banks

32 companies under coverage.

Coverage

Regional Banks

Bank Ozk (OZK)

BUY. 12-month probability-weighted target $52 (+17% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

OZKEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +34.7%

Equity Research

Western Alliance Bancorporation (WAL)

HOLD. 12-month probability-weighted target $80 (+7% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

WALEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +20.6%

Equity Research

Zions Bancorporation (ZION)

HOLD. 12-month probability-weighted target $70 (+12% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

ZIONEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +20.2%

Equity Research

International Bancshares Corporation (IBOC)

HOLD. 12-month probability-weighted target $77 (+13% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

IBOCEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +13.8%

Equity Research

Columbia Banking System Inc (COLB)

BUY. 12-month probability-weighted target $33 (+17% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

COLBEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +7.9%

Equity Research

Glacier Bancorp Inc (GBCI)

BUY. 12-month probability-weighted target $53 (+24% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

GBCIEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +7.1%

Equity Research

UMB Financial Corporation (UMBF)

HOLD. 12-month probability-weighted target $145 (+11% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

UMBFEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +5.8%

Equity Research

Regions Financial Corporation (RF)

HOLD. 12-month probability-weighted target $31 (+13% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

RFEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +5.5%

Equity Research

Associated Banc-Corp (ASB)

HOLD. 12-month probability-weighted target $30 (+3% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

ASBEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +5.2%

Equity Research

East West Bancorp Inc (EWBC)

HOLD. 12-month probability-weighted target $138 (+10% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

EWBCEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +5.0%

Equity Research

F.N.B. Corp (FNB)

HOLD. 12-month probability-weighted target $19 (+9% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

FNBEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +2.8%

Equity Research

First Horizon Corporation (FHN)

HOLD. 12-month probability-weighted target $26 (+11% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

FHNEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +2.5%

Equity Research

Wintrust Financial Corporation (WTFC)

HOLD. 12-month probability-weighted target $157 (+9% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

WTFCEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +2.3%

Equity Research

KeyCorp (KEY)

BUY. 12-month probability-weighted target $24 (+22% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

KEYEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +2.1%

Equity Research

SouthState Corporation (SSB)

HOLD. 12-month probability-weighted target $104 (+4% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

SSBEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +1.8%

Equity Research

Pinnacle Financial Partners, Inc. (PNFP)

HOLD. 12-month probability-weighted target $102 (+8% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

PNFPEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -0.2%

Equity Research

Commerce Bancshares Inc (CBSH)

HOLD. 12-month probability-weighted target $60 (+10% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

CBSHEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -0.3%

Equity Research

Old National Bancorp (ONB)

HOLD. 12-month probability-weighted target $26 (+6% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

ONBEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -0.4%

Equity Research

Valley National Bancorp (VLY)

HOLD. 12-month probability-weighted target $14 (+11% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

VLYEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -1.0%

Equity Research

First Hawaiian Inc (FHB)

HOLD. 12-month probability-weighted target $26 (+5% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

FHBEquity ResearchMonte Carlo

11 October 2026Rating: HOLD · Fair value vs price -1.1%

Equity Research

Texas Capital Bancshares, Inc. (TCBI)

HOLD. 12-month probability-weighted target $103 (+14% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

TCBIEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -1.1%

Equity Research

Home BancShares Inc (HOMB)

HOLD. 12-month probability-weighted target $30 (+7% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

HOMBEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -1.1%

Equity Research

Huntington Bancshares Incorporated (HBAN)

HOLD. 12-month probability-weighted target $18 (+14% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

HBANEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -2.0%

Equity Research

M&T Bank Corporation (MTB)

HOLD. 12-month probability-weighted target $247 (+13% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

MTBEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -2.2%

Equity Research

Cullen/Frost Bankers Inc (CFR)

HOLD. 12-month probability-weighted target $165 (+10% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

CFREquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -4.6%

Equity Research

United Bankshares Inc (UBSI)

HOLD. 12-month probability-weighted target $48 (+5% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

UBSIEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -8.6%

Equity Research

First Financial Bankshares Inc (FFIN)

HOLD. 12-month probability-weighted target $35 (+13% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

FFINEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -8.6%

Equity Research

Hancock Whitney Corp (HWC)

HOLD. 12-month probability-weighted target $77 (+7% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

HWCEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -10.1%

Equity Research

Citizens Financial Group, Inc. (CFG)

HOLD. 12-month probability-weighted target $71 (+12% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

CFGEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -10.1%

Equity Research

Prosperity Bancshares Inc (PB)

HOLD. 12-month probability-weighted target $70 (+6% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

PBEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -11.9%

Equity Research

Fifth Third Bancorp (FITB)

HOLD. 12-month probability-weighted target $51 (+1% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

FITBEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -19.0%

Equity Research

Flagstar Financial, Inc. (FLG)

SELL. 12-month probability-weighted target $7 (-39% vs spot). P/E Multiple explains 85% of Monte Carlo outcome variance.

FLGEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -47.9%